Alerts
PDF
Other content recommended for you
- Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs
- News from the European Union
- Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution
- Compliance of e-cigarette refill liquids with regulations on labelling, packaging and technical design characteristics in nine European member states
- Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
- Health impact assessment: assessing opportunities and barriers to intersectoral health improvement in an expanded European Union
- Simplified consent in cluster randomised trials: the new EU Clinical Trials Regulation does not provide sufficient guidance
- Regulating the advertising of genetic tests in Europe: a balancing act
- Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
- Running an international paediatric non-commercial clinical trial